Ticlid and Celestone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ticlid (ticlopidine hydrochloride) and Celestone (betamethasone). Common drug interactions include blood oestrogen decreased among females.

The phase IV clinical study analyzes what interactions people have when they take Ticlid and Celestone. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Ticlid?

Ticlid has active ingredients of ticlopidine hydrochloride. eHealthMe is studying from 3,094 Ticlid users. Check the latest studies of Ticlid.

What is Celestone?

Celestone has active ingredients of betamethasone. It is often used in bursitis. eHealthMe is studying from 1,788 Celestone users. Check the latest studies of Celestone.



On Jul, 06, 2026

13 people who take Ticlid and Celestone together, and have interactions are studied.

Ticlid and Celestone drug interactions.

What are the common drug interactions of Ticlid and Celestone, by gender? *:

female:

  1. Blood oestrogen decreased
  2. Depression
  3. Upper respiratory tract infection
  4. Weight increased
  5. Drug ineffective
  6. Vomiting
  7. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  8. Arteriosclerosis (thickening and hardening of arteries)
  9. Fall
  10. Nausea (feeling of having an urge to vomit)

male:

n/a

What are the common drug interactions of Ticlid and Celestone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Blood oestrogen decreased
  2. Depression
  3. Upper respiratory tract infection
  4. Weight increased
  5. Drug ineffective
  6. Vomiting
  7. Myoclonus (a brief, involuntary twitching of a muscle or a group of muscles)
  8. Arteriosclerosis (thickening and hardening of arteries)
  9. Fall
  10. Nausea (feeling of having an urge to vomit)

60+:

n/a

What are the existing conditions these people have? *

  1. Pain: 9 people, 69.23%

* Approximation only. Some reports may have incomplete information.

Do you take Ticlid and Celestone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ticlid and Celestone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ticlid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Celestone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ticlid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Celestone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ticlopidine hydrochloride and betamethasone (the active ingredients of Ticlid and Celestone, respectively), and Ticlid and Celestone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: